These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26318038)

  • 1. Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration.
    Kadota K; Eguchi T; Villena-Vargas J; Woo KM; Sima CS; Jones DR; Travis WD; Adusumilli PS
    Oncotarget; 2015 Sep; 6(29):27505-18. PubMed ID: 26318038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.
    Kadota K; Nitadori J; Sarkaria IS; Sima CS; Jia X; Yoshizawa A; Rusch VW; Travis WD; Adusumilli PS
    Cancer; 2013 Mar; 119(5):931-8. PubMed ID: 23096929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.
    Suzuki K; Kadota K; Sima CS; Nitadori J; Rusch VW; Travis WD; Sadelain M; Adusumilli PS
    J Clin Oncol; 2013 Feb; 31(4):490-8. PubMed ID: 23269987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.
    Kadota K; Yeh YC; Villena-Vargas J; Cherkassky L; Drill EN; Sima CS; Jones DR; Travis WD; Adusumilli PS
    Chest; 2015 Sep; 148(3):711-721. PubMed ID: 25836013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma.
    Kadota K; Buitrago D; Lee MC; Villena-Vargas J; Sima CS; Jones DR; Travis WD; Adusumilli PS
    Lung Cancer; 2015 Sep; 89(3):329-36. PubMed ID: 26141216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.
    Raso MG; Behrens C; Herynk MH; Liu S; Prudkin L; Ozburn NC; Woods DM; Tang X; Mehran RJ; Moran C; Lee JJ; Wistuba II
    Clin Cancer Res; 2009 Sep; 15(17):5359-68. PubMed ID: 19706809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.
    Nitadori J; Bograd AJ; Kadota K; Sima CS; Rizk NP; Morales EA; Rusch VW; Travis WD; Adusumilli PS
    J Natl Cancer Inst; 2013 Aug; 105(16):1212-20. PubMed ID: 23926067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M
    Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.
    Dougherty SM; Mazhawidza W; Bohn AR; Robinson KA; Mattingly KA; Blankenship KA; Huff MO; McGregor WG; Klinge CM
    Endocr Relat Cancer; 2006 Mar; 13(1):113-34. PubMed ID: 16601283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
    Kadota K; Suzuki K; Kachala SS; Zabor EC; Sima CS; Moreira AL; Yoshizawa A; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
    Mod Pathol; 2012 Aug; 25(8):1117-27. PubMed ID: 22499226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
    Gomez-Fernandez C; Mejias A; Walker G; Nadji M
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):137-41. PubMed ID: 19875957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.
    Shafrir AL; Rice MS; Gupta M; Terry KL; Rosner BA; Tamimi RM; Hecht JL; Tworoger SS
    Gynecol Oncol; 2016 Dec; 143(3):628-635. PubMed ID: 27720231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex.
    Berardi R; Morgese F; Santinelli A; Onofri A; Biscotti T; Brunelli A; Caramanti M; Savini A; De Lisa M; Ballatore Z; Pompili C; Salati M; Mazzanti P; Torniai M; Cascinu S
    Oncotarget; 2016 Dec; 7(50):82648-82657. PubMed ID: 27690341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERα phenotype, estrogen level, and benzo[a]pyrene exposure modulate tumor growth and metabolism of lung adenocarcinoma cells.
    Lin S; Lin CJ; Hsieh DP; Li LA
    Lung Cancer; 2012 Mar; 75(3):285-92. PubMed ID: 21920623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.